Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXM02A
|
||||
Drug Name |
N-[1-(2S-Ethyl-4-oxo-tetrahydro-furan-3S-ylcarbamoyl)-2S-(1-methyl-cyclopentyl)-ethyl]-4-(4-isopropyl-thiazole-2-sulfonylamino)-benzamide
|
||||
Synonyms |
CHEMBL474257
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C28H38N4O6S2
|
||||
Canonical SMILES |
CC[C@@H]1OCC(=O)[C@H]1NC(=O)[C@H](CC2(C)CCCC2)NC(=O)c3ccc(NS(=O)(=O)c4nc(cs4)C(C)C)cc3
|
||||
InChI |
InChI=1S/C28H38N4O6S2/c1-5-23-24(22(33)15-38-23)31-26(35)20(14-28(4)12-6-7-13-28)29-25(34)18-8-10-19(11-9-18)32-40(36,37)27-30-21(16-39-27)17(2)3/h8-11,16-17,20,23-24,32H,5-7,12-15H2,1-4H3,(H,29,34)(H,31,35)/t20-,23-,24+/m0/s1
|
||||
InChIKey |
QUIQWGISSRRKQP-NKKJXINNSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.